A core strategic pillar is to penetrate the regulated diagnostics and therapeutics markets, moving beyond its traditional research focus. This shift requires significant investment in regulatory compliance systems (FDA, EU IVDR), clinical trial support, and specialized commercial teams.
Filing excerpt
Market Expansion Through Innovation & Acquisition. We will leverage our existing portfolio to expand our product offerings into novel research fields and further penetrate diagnostics and therapeutics markets.
What this signalsFilings often name leadership changes, deals and spending plans.
Technologies
sec-10kmarketExpansionGet every 10-K signal for Bio-Techne and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Bio-Techne this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/1787fb9b-2ac8-4a96-ba77-f502dd0afbc9 returns this record as JSON. POST /v1/companies/enrich returns every signal for bio-techne.com.
{
"signal_id": "1787fb9b-2ac8-4a96-ba77-f502dd0afbc9",
"signal_type": "sec-10k",
"signal_subtype": "marketExpansion",
"detected_at": "2026-08-25T07:04:16.242+00:00",
"company": {
"name": "Bio-Techne",
"domain": "bio-techne.com"
},
"data": {
"detail": "A core strategic pillar is to penetrate the regulated diagnostics and therapeutics markets, moving beyond its traditional research focus. This shift requires significant investment in regulatory compliance systems (FDA, EU IVDR), clinical trial support, and specialized commercial teams.",
"summary": "Bio-Techne is executing a strategic expansion into diagnostics and therapeutics markets",
"excerpts": "Market Expansion Through Innovation & Acquisition. We will leverage our existing portfolio to expand our product offerings into novel research fields and further penetrate diagnostics and therapeutics markets.",
"relevance": 0.8,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/842023/000110465926100322/tech-20260630x10k.htm",
"filing_date": "2026-08-24",
"filing_year": 2026,
"sales_relevance": "Scaling infrastructure needed",
"signal_category": "market",
"technologies_mentioned": [
"diagnostics",
"therapeutics"
]
}
}
curl https://signals.autobound.ai/v1/signals/1787fb9b-2ac8-4a96-ba77-f502dd0afbc9 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"bio-techne.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.